FDA Approves Tirzepatide for Obstructive Sleep Apnea in Obesity
Tirzepatide’s approval marks the first and only prescription medicine available for adults with moderate-to-severe obstructive sleep apnea and obesity.
Tirzepatide’s approval marks the first and only prescription medicine available for adults with moderate-to-severe obstructive sleep apnea and obesity.
The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about a new model of value-based…
A 50-year-long study has revealed the secret to financial success, and it has nothing to do with academic performance, professional connections or work ethic.
A phase 3 trial shows promising data for brexpiprazole with sertraline for PTSD symptoms ahead of the supplemental new drug application’s PDUFA date in February…
Health insurers are irked that the Centers for Medicare and Medicaid Services is ending the Medicare Advantage Value-Based Insurance Design model five years early.
Proposed sensors include unusual crack-opening behavior exploiting mechanical meta-materials for exceptional strain sensitivity.
She went to her doctor for temporary contraceptive implants in her arm. Instead, he made an appointment for her to get a tubal ligation
Like it or not, it’s that time of year when the temperature drops. While it may be tempting to hibernate over the winter, we all…
Forget the conference room with HR. Some companies, including GM, are cutting out human contact altogether when eliminating jobs.
Reflecting on research discoveries reported in 2024
The Food and Drug Administration released final rules on labeling foods as “healthy,” tightening limits for sugar, sodium and saturated fat.